Tao Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tao Lin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Feng Gao
Department of Hepato-pancreato-biliary Tumor Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
1 shared publication Houmin Fan
Guizhou Medical University, Guiyang, China
1 shared publication- HuaZhen Xu
Department of Hematology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei, China
1 shared publication - Li Zhu
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China
1 shared publication Lixia Dai
Department of Hematology, Suizhou Hospital, Hubei University of Medicine, Suizhou, Hubei, China
1 shared publication- Qiuju Mou
Department of Blood Transfusion The Affiliated Hospital of Guizhou Medical University Guizhou China
1 shared publication
Latest Publications
- 1 June 2021
- Published by Wiley in IUBMB Life
- Vol. 73 (9) , 1103-1114
lncRNA XIST knockdown suppresses hypoxia/reoxygenation (H/R)‐induced apoptosis of H9C2 cells by regulating miR‐545‐3p/G3BP2
This study was aimed at determining the roles and functions of lncRNA XIST/miR‐545‐3p/G3BP2 axis during hypoxia/reoxygenation (H/R)‐induced H9C2 cell apoptosis. H9C2 cells were distributed into two groups, the H/R injury and control groups. High‐throughput lncRNA sequencing was applied in the determination of differentially expressed lncRNAs between H/R‐induced H9C2 cells and normal H9C2 cells. Real‐time polymerase chain reactions (RT‐PCR) were used to confirm the expression levels of lncRNA XIST in H/R‐induced H9C2 cells. H9C2 cells were then transfected with lncRNA XIST recombinant plasmid (lncRNA XIST), sh‐LINC XIST, agomiR‐545‐3p, antagomiR‐545‐3p, pcDNA‐G3BP2, sh‐G3BP2, and a corresponding negative control (NC). Bioinformatic analyses revealed that MiR‐545‐3p was a target for lncRNA XIST. This finding was confirmed by dual‐luciferase reporter assay. The degree of cell apoptosis was evaluated by a flow cytometer. RT‐PCR and western blot were performed to assess the apoptotic‐related proteins in each group. A total of 859 differentially expressed lncRNAs (up‐regulated = 502, down‐regulated = 357) were identified. LncRNA XIST was found to be down‐regulated in H/R‐induced H9C2 cells while miR‐545‐3p was distinctly up‐regulated. miR‐545‐3p was established to be a direct target for LncRNA XIST. LncRNA XIST significantly enhanced the apoptotic rate, while its inhibition suppressed the apoptotic rate. AgomiR‐545‐3p partially blocked the lncRNA XIST and enhanced the apoptosis of H/R‐induced H9C2 cells. Moreover, miR‐545‐3p was shown to be a direct target for G3BP2. The overexpression of G3BP2 partially reversed the apoptotic effects of miR‐545‐3p on H/R‐induced H9C2 cells. lncRNA XIST/miR‐545‐3p/GBP2 was found to be an apoptotic regulator in H/R‐induced H9C2 cells.
- 1 June 2021
- Published by Wiley in IUBMB Life
- Vol. 73 (9) , 1103-1114
lncRNA XIST knockdown suppresses hypoxia/reoxygenation (H/R)‐induced apoptosis of H9C2 cells by regulating miR‐545‐3p/G3BP2
This study was aimed at determining the roles and functions of lncRNA XIST/miR‐545‐3p/G3BP2 axis during hypoxia/reoxygenation (H/R)‐induced H9C2 cell apoptosis. H9C2 cells were distributed into two groups, the H/R injury and control groups. High‐throughput lncRNA sequencing was applied in the determination of differentially expressed lncRNAs between H/R‐induced H9C2 cells and normal H9C2 cells. Real‐time polymerase chain reactions (RT‐PCR) were used to confirm the expression levels of lncRNA XIST in H/R‐induced H9C2 cells. H9C2 cells were then transfected with lncRNA XIST recombinant plasmid (lncRNA XIST), sh‐LINC XIST, agomiR‐545‐3p, antagomiR‐545‐3p, pcDNA‐G3BP2, sh‐G3BP2, and a corresponding negative control (NC). Bioinformatic analyses revealed that MiR‐545‐3p was a target for lncRNA XIST. This finding was confirmed by dual‐luciferase reporter assay. The degree of cell apoptosis was evaluated by a flow cytometer. RT‐PCR and western blot were performed to assess the apoptotic‐related proteins in each group. A total of 859 differentially expressed lncRNAs (up‐regulated = 502, down‐regulated = 357) were identified. LncRNA XIST was found to be down‐regulated in H/R‐induced H9C2 cells while miR‐545‐3p was distinctly up‐regulated. miR‐545‐3p was established to be a direct target for LncRNA XIST. LncRNA XIST significantly enhanced the apoptotic rate, while its inhibition suppressed the apoptotic rate. AgomiR‐545‐3p partially blocked the lncRNA XIST and enhanced the apoptosis of H/R‐induced H9C2 cells. Moreover, miR‐545‐3p was shown to be a direct target for G3BP2. The overexpression of G3BP2 partially reversed the apoptotic effects of miR‐545‐3p on H/R‐induced H9C2 cells. lncRNA XIST/miR‐545‐3p/GBP2 was found to be an apoptotic regulator in H/R‐induced H9C2 cells.
- Open Access
- 10 May 2021
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 18 (1) , 1-11
Combined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease
Background: Mitochondrial dysfunction has been implicated as a significant factor in the liver disease process. Blueberry juice and probiotics (BP) synergistically improve liver function in alcoholic fatty liver disease (AFLD), although the mechanism for this effect was unclear. This study aims to investigate the effect and specific mechanisms of BP on AFLD. Methods: C57/BL6 mice were randomly divided into seven groups: CG (control), MG (AFLD model), BJ (MG mice treated with blueberry), BJB (MG mice treated with BP), SI (AFLD mice treated with SIRT1 siRNA), BJSI (SI mice treated with blueberry), and BJBSI (SI mice treated with BP). The mice were fed an alcohol liquid diet for 10 days to establish the AFLD model, and subjected to BP and SIRT1 siRNA intervention for 10 days. Liver pathology was performed on day 11, and biochemical and molecular analyses of liver mitochondria were employed on day 12. Results: BP significantly ameliorated hepatic mitochondrial injury, mitochondrial swelling, and hepatic necrosis in AFLD. BP alleviated hepatic mitochondrial dysfunction by increasing the expression of succinate dehydrogenase and cytochrome c oxidase, increasing respiratory control rate and the ADP/O ratio, and facilitating the synthesis of energy-related molecules. Besides, BP increased the expression of glutathione and superoxide dismutase, and inhibited malondialdehyde expression and reactive oxygen species activity. BP-induced sirtuin 1 (SIRT1), which activates peroxisome proliferator-activated receptor-gamma coactivator-1α, both of which mediate mitochondrial homeostasis. SIRT1 silencing suppressed the BP-induced changes in liver mitochondria, blunting its efficacy. Conclusions: The ingredients of BP ameliorate hepatocyte mitochondrial dysfunction in AFLD mice.
- 10 May 2021
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 18 (1) , 1-11
Open AccessCombined intake of blueberry juice and probiotics ameliorate mitochondrial dysfunction by activating SIRT1 in alcoholic fatty liver disease
Background: Mitochondrial dysfunction has been implicated as a significant factor in the liver disease process. Blueberry juice and probiotics (BP) synergistically improve liver function in alcoholic fatty liver disease (AFLD), although the mechanism for this effect was unclear. This study aims to investigate the effect and specific mechanisms of BP on AFLD. Methods: C57/BL6 mice were randomly divided into seven groups: CG (control), MG (AFLD model), BJ (MG mice treated with blueberry), BJB (MG mice treated with BP), SI (AFLD mice treated with SIRT1 siRNA), BJSI (SI mice treated with blueberry), and BJBSI (SI mice treated with BP). The mice were fed an alcohol liquid diet for 10 days to establish the AFLD model, and subjected to BP and SIRT1 siRNA intervention for 10 days. Liver pathology was performed on day 11, and biochemical and molecular analyses of liver mitochondria were employed on day 12. Results: BP significantly ameliorated hepatic mitochondrial injury, mitochondrial swelling, and hepatic necrosis in AFLD. BP alleviated hepatic mitochondrial dysfunction by increasing the expression of succinate dehydrogenase and cytochrome c oxidase, increasing respiratory control rate and the ADP/O ratio, and facilitating the synthesis of energy-related molecules. Besides, BP increased the expression of glutathione and superoxide dismutase, and inhibited malondialdehyde expression and reactive oxygen species activity. BP-induced sirtuin 1 (SIRT1), which activates peroxisome proliferator-activated receptor-gamma coactivator-1α, both of which mediate mitochondrial homeostasis. SIRT1 silencing suppressed the BP-induced changes in liver mitochondria, blunting its efficacy. Conclusions: The ingredients of BP ameliorate hepatocyte mitochondrial dysfunction in AFLD mice.
- Open Access
- 5 July 2016
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 12 (3) , 1705-1710
Effects of diabetic keratopathy on corneal optical density, central corneal thickness, and corneal endothelial cell counts
Diabetic keratopathy is an ocular complication that occurs with diabetes. In the present study, the effect of diabetic keratopathy on corneal optical density, central corneal thickness, and corneal endothelial cell count was investigated. One hundred and eighty diabetic patients (360 eyes) were enrolled in the study during the period from March, 2012 to March, 2013. The patients were divided into three age groups: 10 years, with 60 patients per group (120 eyes). During the same period, 60 healthy cases (120 eyes) were selected and labeled as the normal control group. The Pentacam was used to measure the corneal optical density, and central corneal thickness. Specular microscopy was used to examine the corneal endothelial cell density. The coefficient of partial correlation was used to control age and correlate the analysis between the corneal optical density, corneal endothelial cell density, and central corneal thickness. The stage of the disease, the medial and intimal corneal optical density and central corneal thickness was analyzed in the diabetes group. The corneal optical density in the diabetes group increased compared with that of the normal control group. The medial and intimal corneal optical density and central corneal thickness were positively correlated with the course of the disease. However, the corneal endothelial cell density was not associated with the course of diabetes. There was a positive association between the medial and intimal corneal optical density and central corneal thickness of the diabetic patients. In conclusion, the results of the present study show that medial and intimal corneal optical density and central corneal thickness were sensitive indicators for early diabetic keratopathy.
- 5 July 2016
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 12 (3) , 1705-1710
Open AccessEffects of diabetic keratopathy on corneal optical density, central corneal thickness, and corneal endothelial cell counts
Diabetic keratopathy is an ocular complication that occurs with diabetes. In the present study, the effect of diabetic keratopathy on corneal optical density, central corneal thickness, and corneal endothelial cell count was investigated. One hundred and eighty diabetic patients (360 eyes) were enrolled in the study during the period from March, 2012 to March, 2013. The patients were divided into three age groups: 10 years, with 60 patients per group (120 eyes). During the same period, 60 healthy cases (120 eyes) were selected and labeled as the normal control group. The Pentacam was used to measure the corneal optical density, and central corneal thickness. Specular microscopy was used to examine the corneal endothelial cell density. The coefficient of partial correlation was used to control age and correlate the analysis between the corneal optical density, corneal endothelial cell density, and central corneal thickness. The stage of the disease, the medial and intimal corneal optical density and central corneal thickness was analyzed in the diabetes group. The corneal optical density in the diabetes group increased compared with that of the normal control group. The medial and intimal corneal optical density and central corneal thickness were positively correlated with the course of the disease. However, the corneal endothelial cell density was not associated with the course of diabetes. There was a positive association between the medial and intimal corneal optical density and central corneal thickness of the diabetic patients. In conclusion, the results of the present study show that medial and intimal corneal optical density and central corneal thickness were sensitive indicators for early diabetic keratopathy.